-transparent.png){kind=logo}
An overall study, accompanied by some statistics, is presented of delayed bone marrow injuries caused by drugs, such as chloramphenicol, phenylbutazone, oxyphenbutazone, gold salts, sulphamides and diphenylhydantoin. Unanimous agreement as to the aetiological interpretation of isolated cases, the seriousness of marrow damage, and the results obtained by treatment can be observed in various countries. The available epidemiological data are incomplete, though they point to a parallel between the appearance of panmyelopathy after chloramphenicol and the consumption of this drug. First noted in the U.S., this relationship later became apparent in several European countries and eventually in West Germany. Frequencies range from 1 per 6,000 to 1 per 36,000 subjects treated in California, Hamburg and Sweden.
K Hausmann, and
G Skrandies, and
P Sachtleben
October 1988,
Presse medicale (Paris, France : 1983),
K Hausmann, and
G Skrandies, and
P Sachtleben
January 2015,
BoneKEy reports,
K Hausmann, and
G Skrandies, and
P Sachtleben
January 1986,
Psychiatric medicine,
K Hausmann, and
G Skrandies, and
P Sachtleben
July 2018,
Seminars in diagnostic pathology,
K Hausmann, and
G Skrandies, and
P Sachtleben
January 2023,
Osteoarthritis and cartilage,
K Hausmann, and
G Skrandies, and
P Sachtleben
January 1993,
Wiadomosci lekarskie (Warsaw, Poland : 1960),
K Hausmann, and
G Skrandies, and
P Sachtleben
April 1989,
Lancet (London, England),
K Hausmann, and
G Skrandies, and
P Sachtleben
August 2003,
Seminars in diagnostic pathology,
K Hausmann, and
G Skrandies, and
P Sachtleben
January 2004,
Breast cancer research : BCR,
K Hausmann, and
G Skrandies, and
P Sachtleben
June 1976,
American journal of clinical pathology,
